Halozyme Therapeutics shares owned by nVerses Capital
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by nVerses Capital
from 13F filings
Historical chart of nVerses Capital investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by nVerses Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $73k | 1.8k | 40.68 |